Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001-Reference-Cited by-同舟云学术

Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001

Published:2023-01-12 Issue:1 Volume:14 Page:1-13
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Li Xiaofan¹,Abrahams Cristina¹,Yu Abigail¹,Embry Millicent¹,Henningsen Robert¹,DeAlmeida Venita¹,Matheny Shannon²,Kline Toni¹,Yam Alice¹,Stafford Ryan¹,Hallam Trevor¹,Lupher Mark¹,Molina Arturo²

Affiliation:

1. Research Development, Sutro Biopharma, South San Francisco, CA 94080, USA

2. Clinical Development, Sutro Biopharma, South San Francisco, CA 94080, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Reference31 articles.

1. Impact of Rituximab (Rituxan) on the Treatment of B-Cell Non-Hodgkin’s Lymphoma;Smith;P T,2010

2. A decade of rituximab: improving survival outcomes in non-Hodgkin’s lymphoma;Molina;Annu Rev Med,2008

3. Development of the Bruton’s tyrosine kinase inhibitor ibrutinib for B cell malignancies;Zhuang;Ann N Y Acad Sci,2015

4. A comprehensive review of lenalidomide in B-cell non-Hodgkin lymphoma;Tuscano;Ther Adv Hematol,2016

5. 2016 US lymphoid malignancy statistics by World Health Organization subtypes;Flowers;CA Cancer J Clin,2016

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. T cell-redirecting therapies in hematological malignancies: Current developments and novel strategies for improved targeting;Molecular Therapy;2024-09

2. Identification and Validation of Prognostic Model for Tumor Microenvironment-Associated Genes in Bladder Cancer Based on Single-Cell RNA Sequencing Data Sets;JCO Precision Oncology;2024-08

3. Evaluation in mice of cell-free produced CT584 as a Chlamydia vaccine antigen;2024-06-06

4. Mouse models for cancer research – current state and the perspective;Neoplasma;2024

5. The multifaceted role of macrophage migration inhibitory factor (MIF) in innate tumor immunity;Reference Module in Life Sciences;2024